Bunny Ellerin
Co-founder and CEO

Bunny Ellerin is a Harvard-trained healthcare entrepreneur and advisor who is highly sought-after for her industry expertise and extensive network. She has helped build and sell companies, launched several thriving networking organizations, and has become a recognized force in leading New York City’s transformation into a thriving hub of healthcare innovation. An expert in digital health, Bunny has her pulse on — and relationships to — the companies and people defining healthcare’s future

Bunny is Co-founder and CEO of NYC Health Business Leaders (NYCHBL), a community of 5,000 healthcare executives, entrepreneurs, innovators, and investors. NYCHBL fosters collaboration, discussion, and innovation through networking events, thought leadership and its widely read New York Healthcare Innovation reports, which analyze the companies, investors, and trends driving healthcare entrepreneurship and investment. NYCHBL also publishes the NYC Digital Health 100, an annual selection of the most promising start-ups in the region.

Bunny was director of Columbia Business School’s Healthcare and Pharmaceutical Management Program (HPM) from 2016-2021, which she transformed into one of the most prestigious healthcare tracks in the country. As a result of her leadership, vision, and ability to drive results, she secured HPM’s first-ever endowed gift of $2.25M and an additional $1M in non-endowed funding. She revamped the curriculum, increased applications to HPM by 20%, improved yield by 30%, organized 60 career and industry events, and facilitated 100+ new internships and full-time job placements.

Previously, Bunny spent 20 years in leadership positions in various healthcare organizations including Onsite Dental, Interbrand Health, PPD, Intouch Group, TCTMD, Vivra, and Advanced Health. During that period, she launched the Harvard Business School Healthcare Alumni Association (HBSHAA) which celebrated its 20th anniversary in 2019. To recognize her impact, HBSHAA created the Ellerin Alumni Achievement Award, given to an outstanding leader annually.

Bunny is frequently quoted as a national healthcare expert in media outlets such as Bloomberg, CBS News, Fast Company, Forbes, NPR, and USA Today. She was named to Crain’s Notable in Health Care (2021 and 2019) and sits on the board of The Fund for PublicHealth NYC.

Bunny has an MBA from Harvard Business School and BA in Political Science from Columbia University.

Dr. Yin Ho
Co-founder and Chairman

Yin is Chief Product Officer for Aetion and a veteran in health information technology and data analytics. She was most recently the Founder and former CEO of Context Matters Inc., a health economics integrated data and technology company based in New York City, acquired in late 2017 by Decision Resources Group.

Trained as an emergency medicine physician, Yin stepped away from medicine in 1998 to pursue opportunities in the emerging eHealth industry. Her most recent enterprise was the founding, building, and eventual sale of Context Matters Inc. Context Matters’ flagship product is the Market Access PlatformTM– a cloud based data analytics subscription platform for global biopharmaceutical companies’ health economics and market access teams.

Prior to founding Context Matters, she was vice president of corporate strategy at Medidata Solutions (MDSO). She has also held senior positions at Pfizer (PFE) and led many cutting-edge initiatives and investments in eHealth including ePrescribing infrastructure and small physician EHR implementation.

Yin is committed to making NYC a recognized capital of healthcare innovation. In 2009, she co-founded and currently serves on the board of NYC Health Business Leaders. She also serves on the Founding Board for the City University of New York (CUNY) School of Public Health as well as a number of other boards and advisory boards including PS3til6 (afterschool program), Pocket Lobby (a non-profit Federal policy information application), and eLab (as part of the NYC Economic Development Corporation).

Yin received a BA from Brown University, MD from Yale University School of Medicine, and MBA from Harvard Business School.